The epidermal growth factor receptor (EGFR) was assessed in 52 breast and 46 ovarian biopsies by the radio ligand binding assay and/or the immunoperoxidase technique. A direct comparison of the two methods was undertaken in 27 breast and 32 ovarian biopsies. The results of both methods correlated positively (r = 0.59) in malignant tumours (n = 34), but not in benign lesions (n = 16) nor in normal tissues (n = 9). The different results may be explained by the fact that different aspects were measured by the two methods, while the biochemical assay assessed the receptor binding capacity, the immunohistochemical method detected an EGFR epitope. Since the histochemical method allows the localization of EGFR positive cells and the biochemical assay gives a quantitative measure, both methods together give more information on the receptor situation. A comparison of the results of these methods used simultaneously, rather than alternating one method with another improves the degree of accuracy of evaluation.

Download full-text PDF

Source

Publication Analysis

Top Keywords

breast ovarian
12
epidermal growth
8
growth factor
8
factor receptor
8
ovarian biopsies
8
comparison methods
8
biochemical assay
8
methods
5
[biochemical immunohistochemical
4
immunohistochemical detection
4

Similar Publications

Background: Randomized clinical trials (RCTs) are fundamental to evidence-based medicine, but their real-world impact on clinical practice often remains unmonitored. Leveraging large-scale real-world data can enable systematic monitoring of RCT effects. We aimed to develop a reproducible framework using real-world data to assess how major RCTs influence medical practice, using two pivotal surgical RCTs in gynaecologic oncology as an example-the LACC (Laparoscopic Approach to Cervical Cancer) and LION (Lymphadenectomy in Ovarian Neoplasms) trials.

View Article and Find Full Text PDF

This research aims to optimize adjuvant ovarian function suppression (OFS) for premenopausal Indian women with hormone receptor-positive (HR+) /human epidermal growth factor receptor 2-negative (HER2-) early breast cancer (eBC). To address specific challenges identified in clinical practice, a comprehensive questionnaire consisting of 21 statements was developed. These statements were reviewed and validated by a scientific committee, ensuring their accuracy and relevance to the study's objectives.

View Article and Find Full Text PDF

Cancer, a leading cause of global mortality, remains a significant challenge to increasing life expectancy worldwide. Forkhead Box R2 (FOXR2), identified as an oncogene within the FOX gene family, plays a crucial role in developing various endoderm-derived organs. Recent studies have elucidated FOXR2-related pathways and their involvement in both tumor and non-tumor diseases.

View Article and Find Full Text PDF

ZNF165: A Pan-Cancer Biomarker with Prognostic and Therapeutic Potential.

Protein Pept Lett

January 2025

Scientific Research Center, Beijing ChosenMed Clinical Laboratory Co., Ltd. 101, 1F, Building 3, No.156 Jinghai 4th Road, Beijing Economic and Technological Development Zone, Beijing, 100176, China.

Background: The role of ZNF165 in only a few tumors has been reported. ZNF165 plays an important role in liver cancer, gastric cancer, and breast cancer, especially in regulating the immune microenvironment, promoting tumor cell proliferation and migration, and serving as a potential target for immunotherapy.

Objective: This study aimed to enhance an understanding of how the ZNF165 gene functions and influences cancer development.

View Article and Find Full Text PDF

Background: Dermatomyositis is a chronic inflammatory condition affecting muscles and skin, often associated with an increased risk of cancer. Specific autoantibodies, including anti-TIF1 (Transcription Intermediary Factor 1), have been linked to this risk. We present a case of dermatomyositis in a male patient positive for anti-TIF1 antibodies, subsequently diagnosed with squamous cell carcinoma of the tonsil, a novel association not previously documented.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!